Sign in

You're signed outSign in or to get full access.

SunOpta (STKL)

--

Earnings summaries and quarterly performance for SunOpta.

Recent press releases and 8-K filings for STKL.

SunOpta Updates on Business Evolution, Growth, and 2025 Guidance
STKL
Guidance Update
New Projects/Investments
Revenue Acceleration/Inflection
  • SunOpta has transformed from a commodity-based business to a private label and co-manufacturing solutions provider, primarily in plant-based beverages and fruit snacks, achieving a 13% CAGR and nearly doubling EBITDA since 2020.
  • The company raised its full-year 2025 guidance for revenue midpoint by $3 million and Adjusted EBITDA by $3.5 million, attributing the increase to faster-than-anticipated progress in digesting new volume.
  • SunOpta's capital allocation priorities include maintaining leverage under three times (projected 2.8 times by year-end 2026), funding growth CapEx projects like a new fruit snack line expected to add $40 million in annual revenue, and an aseptic line increasing capacity by 10%.
  • The company anticipates margin expansion in the second half of 2026 through operational efficiencies and investments, with current capacity and planned CapEx expected to support growth through 2028 without needing a new plant.
Jan 12, 2026, 2:30 PM
SunOpta Raises FY 2025 Guidance and Details Growth and Margin Expansion Plans
STKL
Guidance Update
New Projects/Investments
Revenue Acceleration/Inflection
  • SunOpta raised its full-year 2025 guidance, increasing the revenue midpoint by $3 million and Adjusted EBITDA by $3.5 million, attributed to faster-than-anticipated progress in operational efficiencies.
  • The company reports strong growth in its plant-based beverage and fruit snack segments, with the fruit snacks business achieving 21 consecutive quarters of double-digit growth.
  • Strategic capacity expansions, including a new fruit snack line projected to add $40 million in annual revenue and a 10% increase in aseptic capacity, are planned to support growth through 2028.
  • Management expects a $3 million quarterly benefit from its margin improvement plan by the second half of 2026, following the resolution of temporary operational headwinds.
  • Capital allocation priorities focus on maintaining leverage below three times (projected 2.8 times by end of 2026), funding growth CapEx, and executing on the $24 million share buyback plan.
Jan 12, 2026, 2:30 PM
SunOpta Raises FY 2025 Guidance and Details Growth Initiatives
STKL
Guidance Update
New Projects/Investments
Share Buyback
  • SunOpta raised its full-year 2025 guidance, increasing the revenue midpoint by $3 million and adjusted EBITDA by $3.5 million, primarily due to faster-than-anticipated progress on initiatives to digest new volume.
  • The company's plant-based and fruit snacks businesses are experiencing strong growth, with fruit snacks achieving 21 consecutive quarters of double-digit growth and a new production line expected to add $40 million in annual revenue.
  • SunOpta plans to manage growth through 2027 and 2028 with new aseptic and fruit snack lines, without foreseeing the need for a new plant.
  • Capital allocation priorities include maintaining leverage under 3x (targeting 2.8x by the end of 2026), funding growth CapEx projects, and utilizing the $24 million available share buyback plan.
  • While facing some headwinds, such as a $2 million quarterly impact from wastewater constraints until Q2 2026, the company has seen improvements in absorbing new volume, which was initially estimated as a $3 million headwind in Q4 but "really wasn't" an impact.
Jan 12, 2026, 2:30 PM
SunOpta Raises FY 2025 Guidance and Details Growth Strategy
STKL
Guidance Update
New Projects/Investments
Revenue Acceleration/Inflection
  • SunOpta raised its full-year 2025 guidance, increasing the revenue midpoint by $3 million and Adjusted EBITDA by $3.5 million, primarily due to faster-than-anticipated progress in managing new volume.
  • The company reported strong growth, with a 13% CAGR in continuing operations and 21 consecutive quarters of double-digit growth in its better-for-you fruit snacks business.
  • SunOpta is expanding capacity by adding one production line to an existing fruit snacks facility, projected to generate an additional $40 million in annual revenue, and an aseptic line in 2026, which is expected to manage growth through 2028.
  • Management prioritizes maintaining leverage under three times (targeting 2.8 times by year-end 2026), funding growth CapEx, and has $24 million available for share buybacks.
Jan 12, 2026, 2:30 PM
STKL Raises FY 2025 Guidance and Details Growth Initiatives
STKL
Guidance Update
Revenue Acceleration/Inflection
New Projects/Investments
  • SunOpta (STKL) has raised its full year 2025 guidance, increasing the revenue midpoint by $3 million and Adjusted EBITDA by $3.5 million, primarily due to faster-than-anticipated progress in digesting new volume.
  • The company's "Better for you Fruit Snacks" segment has achieved 21 consecutive quarters of double-digit growth and is expanding capacity with a new production line expected to add $40 million in annual revenue.
  • Operational headwinds from absorbing new volume are improving, with the estimated impact for Q4 2025 reduced from $10 million to $7 million, and previous Q1 and Q2 2026 impacts from volume absorption are expected to "go away".
  • Strategic capital allocation priorities include maintaining leverage under 3x (targeting 2.8x by end of 2026), funding growth CapEx projects, and utilizing the $24 million authorized share buyback plan.
  • The plant-based category continues to see high single-digit growth, driven by consumer trends and strong performance in food service and club channels, with the company's overall annual growth for FY 2025 projected at 13%.
Jan 12, 2026, 2:30 PM
SunOpta Raises FY 2025 Guidance and Details Growth Initiatives
STKL
Guidance Update
New Projects/Investments
Revenue Acceleration/Inflection
  • SunOpta raised its full-year 2025 guidance, increasing the revenue midpoint by $3 million and Adjusted EBITDA by $3.5 million, attributing this to faster-than-anticipated progress in integrating new volume.
  • The company's Fruit Snacks business has achieved 21 consecutive quarters of double-digit growth and plans to add a new production line, projected to generate an additional $40 million in annual revenue.
  • Operational headwinds include a $2 million quarterly impact from a wastewater constraint at the Midlothian plant until the second quarter of 2026, though a previously estimated $3 million impact from volume absorption inefficiencies in Q4 2025 was largely mitigated.
  • SunOpta's capital allocation priorities are maintaining leverage below 3x (targeting 2.8x by the end of 2026), funding growth CapEx projects, and utilizing the $24 million share buyback plan.
  • New aseptic and fruit snack lines are expected to support the company's long-term growth targets through 2027 and 2028, with no new plant foreseen.
Jan 12, 2026, 2:30 PM
SunOpta Raises Fiscal 2025 Financial Outlook
STKL
Guidance Update
Revenue Acceleration/Inflection
  • SunOpta Inc. has raised its fiscal 2025 outlook for both revenue and Adjusted EBITDA.
  • The company now expects fiscal 2025 revenue to be between $816 million and $818 million, an increase from the prior outlook of $812 million to $816 million.
  • The updated Adjusted EBITDA outlook for fiscal 2025 is $94 million to $95 million, up from the previous $90 million to $92 million.
  • This revised outlook implies revenue growth of approximately 13% and Adjusted EBITDA growth of 6% to 7% compared to fiscal 2024.
Jan 12, 2026, 12:52 PM
SunOpta Discusses Strong Demand, Capacity Expansion, and Short-Term Operational Headwinds
STKL
New Projects/Investments
Revenue Acceleration/Inflection
Guidance Update
  • SunOpta is experiencing robust demand in its plant-based beverage and fruit snack categories, with the latter growing over 20% and achieving 21 consecutive quarters of double-digit growth. This strong demand has led the company to pull forward capital investments for new production lines.
  • The decision to pull forward investments and onboard new volume resulted in a $10 million headwind to EBITDA in Q4 (2025) due to operational complexities, including wastewater issues at Midlothian and plant shutdowns for new equipment installation.
  • The wastewater constraint at Midlothian is expected to be resolved by the end of Q2 2026, and the company anticipates a return to its margin expansion plan by Q3 2026, targeting 20%+ gross margins by the back half of 2027 and 16%-18% ROIC by late 2026/early 2027.
  • SunOpta has consistently achieved 15%+ volume growth for nine quarters and maintains long-term targets of 8-10% revenue growth and 13-17% EBITDA growth, while prioritizing deleveraging to 2.8x leverage by the end of 2026.
Nov 18, 2025, 2:00 PM
SunOpta Accelerates Investments Amid Strong Demand, Addresses Near-Term Operational Headwinds
STKL
New Projects/Investments
Guidance Update
Revenue Acceleration/Inflection
  • SunOpta is accelerating capital investments, including a new fruit snack line (25% capacity increase) and an aseptic processing line (10% capacity increase), driven by strong demand in plant-based beverages and fruit snacks.
  • The company expects a $10 million headwind to Q4 EBITDA due to operational complexities and wastewater issues at its Midlothian plant, with resolution anticipated by Q2 2026.
  • Management targets achieving a 20%+ gross margin by the second half of 2027 and an ROIC of 16-18% by late 2026/early 2027, while prioritizing deleveraging to maintain under 3 times leverage through 2026.
Nov 18, 2025, 2:00 PM
SunOpta Discusses Strong Demand, Capacity Expansion, and Q4 Operational Headwinds
STKL
New Projects/Investments
Revenue Acceleration/Inflection
Guidance Update
  • SunOpta is experiencing robust demand, with its plant-based beverage category growing in the high single digits and fruit snacks growing over 20% for 21 consecutive quarters.
  • To meet this demand, the company is pulling forward capital investments for new capacity, including a fruit snack line (adding ~$40 million in annualized revenue capacity) and an aseptic processing line (adding ~$65 million in revenue capacity), both anticipated to be operational in late 2026.
  • Operational challenges led to a $10 million headwind to Q4 EBITDA, mainly from wastewater issues at Midlothian (expected fix by end of Q2 2026) and inefficiencies from new volume integration.
  • The company targets 20%+ gross margins by the second half of 2027 and a 16-18% ROIC by late 2026 or early 2027. It also prioritizes deleveraging, aiming to stay below 3x leverage through 2026 and reach 2.8x by year-end 2026.
Nov 18, 2025, 2:00 PM